Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.39 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1033088 | 0.96 | TSHR (0.57) | TSHRTHRBSMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL17090793 | 0.96 | TSHR (0.57) | TSHRTHRBSMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL17090787 | 0.96 | TSHR (0.57) | TSHRTHRBSMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL17090843 | 0.96 | TSHR (0.57) | TSHRTHRBSMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL10416460 | 0.96 | TSHR (0.57) | TSHRTHRBSMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL17090779 | 0.96 | TSHR (0.57) | TSHRTHRBSMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL10416490 | 0.96 | TSHR (0.57) | TSHRTHRBSMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL17090806 | 0.96 | TSHR (0.57) | TSHRTHRBSMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL367967 | 0.96 | TSHR (0.57) | TSHRTHRBSMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL475823 | 0.96 | TSHR (0.57) | TSHRTHRBSMN1; SMN2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1054 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116003916-B | Ultra-soft polypropylene composition and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-08-06 | — | — | CN | claimed |
| CN-116003916-A | Ultra-soft polypropylene composition and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-04-25 | — | — | CN | claimed |
| CN-112351987-A | Non-coordinating anionic activators containing cations with large alkyl groups | 埃克森美孚化学专利公司 | 2021-02-09 | — | — | CN | claimed |
| US-10150822-B2 | Catalyst component for olefin polymerization, preparation method therefor and catalyst thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2018-12-11 | — | — | US | claimed |
| US-20140163185-A1 | CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, PREPARATION METHOD THEREFOR AND CATALYST THEREOF | BEIJING RESEARCH INSTITUTE OF CHEMICAL INDUSTRY CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2014-06-12 | — | — | US | claimed |
| EP-1785413-B1 | ARYLSULFONIC ACID COMPOUND AND USE THEREOF AS ELECTRON-ACCEPTOR MATERIAL | NISSAN CHEMICAL IND LTD (JP) | 2014-01-22 | — | — | EP | claimed |
| US-7736634-B2 | Process for the preparation of polyorganosilylated carboxylate monomers or polymers thereof | SIGMA COATINGS B.V. (NL) | 2010-06-15 | — | — | US | claimed |
| US-7595370-B2 | Reacting cyclosiloxane with unsaturated organosilylated carboxylate monomer or copolymer under presence of catalyst; antifouling paints, marine systems | PPG B.V. (NL) | 2009-09-29 | — | — | US | claimed |
| US-7550760-B2 | Polyacenes and electronic devices generated therefrom | XEROX CORPORATION (US) | 2009-06-23 | — | — | US | claimed |
| EP-1487928-B1 | FILM-FORMING POLYMER AND ANTIFOULING PAINT | JOTUN AS (NO) | 2008-08-13 | — | — | EP | claimed |
| US-20060142516-A1 | Process for the preparation of polyorganosilylated carboxylate monomers or polymers thereof | SIGMA COATINGS B.V. (NL) | 2006-06-29 | — | — | US | claimed |
| WO-2005118564-A2 | METHODS FOR THE SYNTHESIS OF MILNACIPRAN AND CONGENERS THEREOF | COLLEGIUM PHARMACEUTICAL, INC. (US) | 2005-12-15 | — | — | WO | claimed |
| EP-1539861-A1 | PROCESS FOR THE PREPARATION OF POLYORGANOSILYLATED CARBOXYLATE MONOMERS OR POLYMERS THEREOF | Sigmakalon Services B.V. (NL) | 2005-06-15 | — | — | EP | claimed |
| WO-2004007591-A1 | PROCESS FOR THE PREPARATION OF POLYORGANOSILYLATED CARBOXYLATE MONOMERS OR POLYMERS THEREOF | SIGMAKALON SERVICES B.V. (NL) | 2004-01-22 | — | — | WO | claimed |
| EP-1380611-A1 | Process for the preparation of polyorganosilylated carboxylate monomers or polymers thereof | SigmaKalon Group B.V. (NL) | 2004-01-14 | — | — | EP | claimed |
| EP-1208167-B1 | SELF-POLISHING MARINE ANTIFOULING PAINT COMPOSITION COMPRISING SILICON-CONTAINING CO-POLYMERS AND FIBRES | HEMPELS SKIBSFARVE FAB J C (DK) | 2003-07-30 | — | — | EP | claimed |
| US-5663271-A | Polysilanes and method for producing the same | RESEARCH DEVELOPMENT CORPORATION OF JAPAN (JP) | 1997-09-02 | — | — | US | claimed |
| US-5508397-A | Activated macrolactams | ABBOTT LABORATORIES (US) | 1996-04-16 | — | — | US | claimed |
| EP-0073559-B1 | PROCESS FOR PREPARING DESACETOXYCEPHALOSPORANIC ACID | ELI LILLY AND COMPANY (US) | 1986-04-02 | — | — | EP | claimed |
| EP-0073559-A2 | Process for preparing desacetoxycephalosporanic acid | ELI LILLY AND COMPANY (US) | 1983-03-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060142516-A1 | Process for the preparation of polyorganosilylated carboxylate monomers or polymers thereof | C1R, C9, PCBP1 | TSHR 3690/4885THRB 4122/4885SMN1; SMN2 2806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.